For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Cerulean Pharma Inc.

USPTO Granted Patents = 21

CIPO Patents = 5

EPO Patents = 3

Forward Citations = 172

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Mark E Davis (15 out of 135 patents)

Jianjun Cheng (15 out of 23 patents)

Kay T Khin (14 out of 15 patents)

4. J Michael Ramstack (6 out of 44 patents)

5. John Podobinski (5 out of 6 patents)

6. David S Dickey (3 out of 5 patents)

7. Thomas Crawford (1 out of 8 patents)

8. Kat T Khin (1 out of 1 patent)

9. Thomas Schluep (1 patent)

10. Jianjun Cheng (22 patents)

11. John M Ryan (23 patents)

21 patents: Sort by Forward Citations

1. 9598503 - Methods and systems for polymer precipitation and generation of particles (2017-03-21),

2. 9550860 - Cyclodextrin-based polymers for therapeutics delivery (2017-01-24),

3. 8809492 - Method for fabricating nanoparticles (2014-08-19),

4. 8680202 - Cyclodextrin-based polymers for therapeutics delivery (2014-03-25),

5. 8618240 - Methods and systems for generating nanoparticles (2013-12-31),

6. 8609081 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-17),

7. 8603454 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-10),

8. 8580244 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

9. 8580243 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

10. 8580242 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

11. 8546521 - Method for fabricating nanoparticles (2013-10-01),

12. 8518388 - Cyclodextrin-based polymers for therapeutics delivery (2013-08-27),

13. 8475781 - Cyclodextrin-based polymers for therapeutics delivery (2013-07-02),

14. 8404799 - Methods and systems for generating nanoparticles (2013-03-26),

15. 8404662 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-26),

Cerulean Pharma Inc. is a pharmaceutical company focused on developing innovative nanotechnology-based therapies for the treatment of various cancers. Their proprietary nanoparticle-drug conjugate (NDC) technology enables the precise delivery of potent anti-cancer drugs directly to tumors, enhancing their efficacy while reducing systemic toxicity. With a mission to improve patients' lives, Cerulean Pharma Inc. is committed to advancing the field of oncology through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#55 in Waltham, MA

#903 in Massachusetts

#15,182 in US

#29,079 in the World

Waltham, MA, United States of America

Cerulean Pharma Inc.

Forward Citations = 172

8 inventors:

Mark E Davis (15 out of 135 patents)

Jianjun Cheng (15 out of 23 patents)

Kay T Khin (14 out of 15 patents)

4. J Michael Ramstack (6 out of 44 patents)

5. John Podobinski (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…